1887

n South African Medical Journal - Artesunate v. quinine for severe malaria : correspondence

USD

 

Abstract

Severe malaria is a serious and deadly complication of malaria. We searched the literature to identify the current most efficacious pharmacotherapy for severe malaria. A recent Cochrane meta-analysis compared the efficacy of quinine with artesunate for severe malaria. The primary outcome was all-cause death. The meta-analysis included 8 trials. Artesunate reduced the risk of death both in adults (relative risk (RR) 0.61, 95% confidence interval (CI) 0.50 - 0.75; 1 664 participants, 5 trials) and in children (RR 0.76, 95% CI 0.65 - 0.90; 5 765 participants, 4 trials). In addition, artesunate was less likely to cause hypoglycaemia.

Loading

Article metrics loading...

/content/m_samj/103/5/EJC135069
2013-05-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error